文献速递儿科与产科急症重症综合管理与镇静镇痛

新生儿重症监护病房获得性黏质沙雷菌感染发病危险因素分析

[Analysis of risk factors for onset of acquired Serratia marcescens infection in neonatal intensive care unit].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2024-01-01
一句话结论NICU获得性黏质沙雷菌感染占院内感染的14.8%,出生体重≤1.5 kg、NICU住院>45天、机械通气>3天、中心静脉置管>7天及未用益生菌为独立危险因素。

该回顾性病例对照研究纳入宁波大学妇女儿童医院NICU 2017年1月至2023年12月共44例黏质沙雷菌感染发病新生儿与45例定植对照,分析菌群分布及发病危险因素。感染组感染部位以呼吸道为主(43.2%),其次为血流感染(29.6%)、颅内感染(15.9%)、肠道感染(6.8%)和尿路感染(4.5%),无死亡报告。多因素Logistic回归显示出生体重≤1.5 kg、NICU住院>45天、抗生素使用时长、未使用益生菌、机械通气>3天、中心静脉置管>7天为独立危险因素。作者认为口服益生菌可能成为预防NICU获得性黏质沙雷菌感染的新方法。

要点

  • 出生体重≤1.5 kg是NICU获得性黏质沙雷菌感染发病的独立危险因素(OR=5.745,95%CI 1.345-24.549,P=0.018)。
  • 机械通气>3天(OR=5.302,95%CI 1.510-18.619,P=0.009)与中心静脉置管>7天(OR=3.818,95%CI 1.103-13.212,P=0.034)均为独立危险因素。
  • NICU住院>45天(OR=3.642,95%CI 1.102-12.041,P=0.034)与未使用益生菌(OR=3.191,95%CI 1.058-9.627,P=0.039)为独立危险因素。
  • 抗生素使用时长与发病独立相关(OR=0.871,95%CI 0.799-0.949,P=0.002),原文未说明该OR对应的具体参照或单位条件。
  • 感染组呼吸道感染占43.2%(19/44),血流感染占29.6%(13/44),颅内感染占15.9%(7/44),无死亡报告。

适用人群与场景

  • 宁波大学妇女儿童医院NICU 2017年1月至2023年12月收治的新生儿。
  • 感染发病组:有黏质沙雷菌感染相应临床体征和/或症状,且标本分离出黏质沙雷菌的新生儿44例。
  • 定植对照组:同期直肠和/或咽拭子培养黏质沙雷菌阳性、但无临床体征或感染症状的新生儿45例。

研究设计与关键结果

  • 研究类型:回顾性病例对照研究;7年间NICU共收治5972例新生儿,其中297例发生医院获得性感染,44例为黏质沙雷菌感染,占医院获得性感染的14.8%。
  • 感染部位:感染发病组呼吸道43.2%(19/44)、血流感染29.6%(13/44)、颅内感染15.9%(7/44)、肠道感染6.8%(3/44)、尿路感染4.5%(2/44);无死亡报告。
  • 定植对照组呼吸道占86.7%(39/45)、肠道感染占13.3%(6/45),血、脑脊液、尿均未检出病原菌。
  • 单因素分析:感染发病组较定植对照组胎龄更低[天:28.5(26.9,30.0)vs. 32.0(30.1,34.6),P<0.01]、出生体重更低[kg:1.20(0.96,1.44)vs. 1.75(1.45,2.23),P<0.01]、益生菌使用比例更低[29.5%(13/44)vs. 57.8%(26/45),P<0.01]。
  • 单因素分析:感染发病组NICU住院时间更长[天:65.11±23.00 vs. 40.31±20.04,P<0.01]、抗生素使用时间更长[天:23.09±9.57 vs. 11.80±7.19,P<0.01]。
  • 单因素分析:感染发病组机械通气>3天比例更高[61.4%(27/44)vs. 20.0%(9/45),P<0.01]、中心静脉置管>7天比例更高[81.8%(36/44)vs. 28.9%(13/45),P<0.01]。
  • 二分类多因素Logistic回归:出生体重≤1.5 kg(OR=5.745,95%CI 1.345-24.549,P=0.018)、NICU住院>45天(OR=3.642,95%CI 1.102-12.041,P=0.034)、抗生素使用时长(OR=0.871,95%CI 0.799-0.949,P=0.002)、未使用益生菌(OR=3.191,95%CI 1.058-9.627,P=0.039)、机械通气>3天(OR=5.302,95%CI 1.510-18.619,P=0.009)、中心静脉置管>7天(OR=3.818,95%CI 1.103-13.212,P=0.034)为NICU获得性黏质沙雷菌感染发病的独立危险因素。

证据类型、等级与局限

  • 证据类型:回顾性病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,口服益生菌可能成为预防NICU获得性黏质沙雷菌感染的新方法。
  • 对出生体重≤1.5 kg、NICU住院>45天、机械通气>3天或中心静脉置管>7天的新生儿,原文显示这些因素与黏质沙雷菌感染发病独立相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the clinical characteristics of critically ill neonates in the neonatal intensive care unit (NICU) who acquired Serratia marcescens infection for onset or colonization, and to explore the risk factors contributing to the onset of Serratia marcescens infection.

METHODS: A retrospective case-control study was conducted by collecting clinical data from NICU neonates at the Women and Children's Hospital of Ningbo University between January 2017 and December 2023. Forty-four neonates with clinical signs and/or symptoms consistent with Serratia marcescens infection, and with Serratia marcescens isolated from specimens, would be enrolled as the infection onset group, while 45 neonates who tested positive for Serratia marcescens in rectal and/or pharyngeal cultures during the same period, but had no clinical signs or infection symptoms, were enrolled as the colonization control group. The distribution of bacteria in the neonates infected with Serratia marcescens was observed, and clinical data were subjected to univariate and binary multivariate Logistic regression analyses for screening the independent risk factors for onset of acquired Serratia marcescens infection in NICU.

RESULTS: During the 7-year period, 5 972 neonates were admitted to the NICU, of which 297 developed hospital-acquired infections. Among these, 44 neonates were identified with Serratia marcescens infection, accounting for 14.8% of hospital-acquired infections. During the same period, a total of 45 neonates were diagnosed with the colonization of Serratia marcescens, but did not develop any symptoms. The primary infection sites of the neonates in both the colonization control group and infection onset group were respiratory tract, accounting for 86.7% (39/45) and 43.2% (19/44), respectively. The highest rate of infection in the infection onset group was respiratory tract (43.2%), followed by bloodstream infection [29.6% (13/44)], intracranial infection [15.9%, (7/44)], intestinal infection [6.8% (3/44)], and urinary tract infection [4.5% (2/44)]; no deaths were reported. In addition to respiratory tract infection, 13.3% (6/45) of the neonates in the colonization control group had intestinal infection, and no pathogenic bacteria was detected in their blood, cerebrospinal fluid, or urine. Univariate analysis showed that compared with the colonization control group, the neonates in the infection onset group had lower gestational ages [days: 28.5 (26.9, 30.0) vs. 32.0 (30.1, 34.6), P < 0.01], lower birth weights and proportion of probiotic usage [birth weights (kg): 1.20 (0.96, 1.44) vs. 1.75 (1.45, 2.23), probiotic usage: 29.5% (13/44) vs. 57.8% (26/45), both P < 0.01], longer length of NICU stay and duration of antibiotic usage [length of NICU stay (days): 65.11±23.00 vs. 40.31±20.04, duration of antibiotic usage (days): 23.09±9.57 vs. 11.80±7.19, both P < 0.01], and higher proportions of invasive procedures such as mechanical ventilation > 3 days and central venous catheterization > 7 days [mechanical ventilation > 3 days: 61.4% (27/44) vs. 20.0% (9/45), central venous catheterization > 7 days: 81.8% (36/44) vs. 28.9% (13/45), both P < 0.01], indicating that these factors were associated with Serratia marcescens infection onset acquired in NICU. Binary multivariate Logistic regression analysis showed that a birth weight of ≤ 1.5 kg [odds ratio (OR) = 5.745, 95% confidence interval (95%CI) was 1.345-24.549, P = 0.018], a length of NICU stay > 45 days (OR = 3.642, 95%CI was 1.102-12.041, P = 0.034), duration of antibiotic usage (OR = 0.871, 95%CI was 0.799-0.949, P = 0.002), non-usage of probiotics (OR = 3.191, 95%CI was 1.058-9.627, P = 0.039), and invasive procedures such as mechanical ventilation > 3 days (OR = 5.302, 95%CI was 1.510-18.619, P = 0.009), and central venous catheterization > 7 days (OR = 3.818, 95%CI was 1.103-13.212, P = 0.034) were independent risk factors for the onset of NICU-acquired Serratia marcescens infection.

CONCLUSIONS: The incidence of NICU-acquired Serratia marcescens infection is high. Low birth weight, prolonged length of NICU stay, long-term antibiotic usage, and invasive treatments are independent risk factors for the onset of NICU-acquired Serratia marcescens infection. Oral probiotics may be a new method for preventing onset of NICU-acquired Serratia marcescens infection.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li Y, Qiu H, Yang H, et al. [Analysis of risk factors for onset of acquired Serratia marcescens infection in neonatal intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39586718. doi:10.3760/cma.j.cn121430-20240109-00026

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。